EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development and evaluation of a crispr-cas13a-based platform for rapid and ultraprecise detection of rna viruses in clinical respiratory samples

Zahraa Ali Mohammed, Nahid Sabah Aldin Saber, Huda Sabah Jabr, Rashad Imad Al-Zamili, Rahma Majid Al-Allawi, Noor Sabah Jabr

Journal of Modern Techniques in Biology and Allied Sciences · 12.10.2025 · 28-37

DOI: 10.70604/jmtbas.v2i3.98 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Modern Techniques in Biology and Allied Sciences, online erschienen am 12.10.2025. Verfasst von Zahraa Ali Mohammed und 5 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory RNA virus outbreaks have highlighted the urgent need for rapid, accurate, and affordable diagnostic tools. Traditional molecular diagnostics, while effective, often require complex infrastructure and have long turnaround times, limiting their use in resource-limited and point-of-care settings.

Objective

This study aimed to design and evaluate a CRISPR-Cas13a-based detection system for rapid identification of respiratory RNA viruses in clinical samples, focusing on sensitivity, specificity, and clinical utility. Methodology: We developed a CRISPR-Cas13a diagnostic platform integrating reverse transcription isothermal amplification and Cas13a trans-cleavage activity. The assay targeted conserved genomic regions of SARS-CoV-2, influenza A/B, respiratory syncytial virus (RSV), and human metapneumovirus (hMPV). Clinical validation was performed on 847 nasopharyngeal swab specimens from symptomatic patients, using RT-qPCR as the reference standard.

Results

The assay demonstrated high analytical sensitivity with detection limits of 10–20 copies/L for all target viruses. Clinical sensitivity was 96.7% (95% CI: 94.2–98.4) and specificity 99.1% (95% CI: 97.8–99.7). It showed 100% concordance with RT-qPCR in high viral load samples (Ct

Zitieren

APA

Mohammed, Z. A., Saber, N. S. A., Jabr, H. S., Al-Zamili, R. I., Al-Allawi, R. M., & Jabr, N. S. (2025). Development and evaluation of a crispr-cas13a-based platform for rapid and ultraprecise detection of rna viruses in clinical respiratory samples. Journal of Modern Techniques in Biology and Allied Sciences, 28-37. https://doi.org/10.70604/jmtbas.v2i3.98

Vancouver

Mohammed ZA, Saber NSA, Jabr HS, Al-Zamili RI, Al-Allawi RM, Jabr NS. Development and evaluation of a crispr-cas13a-based platform for rapid and ultraprecise detection of rna viruses in clinical respiratory samples. Journal of Modern Techniques in Biology and Allied Sciences. 2025:28-37. doi:10.70604/jmtbas.v2i3.98

BibTeX
@article{Mohammed2025,
  author = {Mohammed, Zahraa Ali and Saber, Nahid Sabah Aldin and Jabr, Huda Sabah and Al-Zamili, Rashad Imad and Al-Allawi, Rahma Majid and Jabr, Noor Sabah},
  title = {Development and evaluation of a crispr-cas13a-based platform for rapid and ultraprecise detection of rna viruses in clinical respiratory samples},
  journal = {Journal of Modern Techniques in Biology and Allied Sciences},
  year = {2025},
  pages = {28--37},
  doi = {10.70604/jmtbas.v2i3.98}
}
Kostenlos starten →